Barriers to Hepatitis C Virus Care and How Federally Qualified Health Centers Can Improve Patient Access to Treatment

BACKGROUND: Despite the availability of direct-acting antiviral agents (DAAs) for hepatitis C virus (HCV) treatment, disparities in HCV care and treatment persist for underserved populations due to demographic-based and insurance-based barriers. We aim to examine the effect of barriers on HCV treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, David, Wong, Robert J., Tessier, Adla, Zapata, Yenice, Saldana, Elsie, Gish, Robert G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822664/
https://www.ncbi.nlm.nih.gov/pubmed/36660471
http://dx.doi.org/10.14740/gr1568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822664/
https://www.ncbi.nlm.nih.gov/pubmed/36660471
http://dx.doi.org/10.14740/gr1568

Ejemplares similares